JANX
NASDAQ · Biotechnology
Janux Therapeutics Inc
$15.85
-0.25 (-1.55%)
Open$15.73
Previous Close$16.10
Day High$16.19
Day Low$15.73
52W High$35.34
52W Low$12.12
Volume—
Avg Volume664.4K
Market Cap966.60M
P/E Ratio—
EPS$-1.84
SectorBiotechnology
Analyst Ratings
Strong Buy
26 analysts
Price Target
+209.8% upside
Current
$15.85
$15.85
Target
$49.10
$49.10
$33.46
$49.10 avg
$61.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.70M | 9.23M | 135.69M |
| Net Income | -110,221,487 | -94,367,711 | 14.63M |
| Profit Margin | -1,136.3% | -1,079.4% | 10.8% |
| EBITDA | -150,977,469 | -136,442,727 | 20.57M |
| Free Cash Flow | — | — | 20.68M |
| Rev Growth | +5.1% | +5.1% | +1.9% |
| Debt/Equity | — | — | 0.42 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |